Change in exercise tolerance · chronic obstructive pulmonary disease (COPD) with depression
1 finding from 1 review
Change in hospital utilisation ‐ not measured · chronic obstructive pulmonary disease (COPD) with depression
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Depressive symptoms · chronic obstructive pulmonary disease (COPD) with depression
1 finding from 1 review
Adverse events (nausea, dizziness) · chronic obstructive pulmonary disease (COPD) with depression
1 finding from 1 review
Treatment efficacy for depression (short term: 8–9 weeks) · anxiety and depression in children and adolescents with long‐term physical conditions
1 finding from 1 review
Treatment efficacy: anxiety short‐term · anxiety and depression in children and adolescents with long‐term physical conditions
1 finding from 1 review
Quality of life short‐term · anxiety and depression in children and adolescents with long‐term physical conditions
1 finding from 1 review
Functioning at · anxiety and depression in children and adolescents with long‐term physical conditions
1 finding from 1 review
Status of long‐term physical condition short‐term · anxiety and depression in children and adolescents with long‐term physical conditions
1 finding from 1 review
Dropouts due to adverse events · anxiety and depression in children and adolescents with long‐term physical conditions
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Suicide‐related behaviour · anxiety and depression in children and adolescents with long‐term physical conditions
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Depression (postintervention) · children and adolescents, aged 10 to 18 years, with long‐term physical conditions
1 finding from 1 review
Anxiety · children and adolescents, aged 10 to 18 years, with long‐term physical conditions
1 finding from 1 review
Secondary outcome: acceptability of treatment · children and adolescents, aged 10 to 18 years, with long‐term physical conditions
1 finding from 1 review
Quality of life (0 to < 1 week postintervention) measured using different scales across studies · children and adolescents, aged 10 to 18 years, with long‐term physical conditions
1 finding from 1 review
Functioning at · children and adolescents, aged 10 to 18 years, with long‐term physical conditions
1 finding from 1 review
Status of long‐term physical condition (postintervention) · children and adolescents, aged 10 to 18 years, with long‐term physical conditions
1 finding from 1 review
Global Impressions scale change item (CGI‐I or similar): no. of responders (acute phase) · adults with SAnD
It is very uncertain whether comparison 1: 5HT1A partial agonists changes global Impressions scale change item (CGI‐I or similar): no. of… compared with placebo (very low certainty).
1 finding from 1 review
Withdrawals due to adverse events · adults with SAnD
It is very uncertain whether comparison 3: anticonvulsant levetiracetam changes dropouts due to adverse events (acute phase) compared with placebo (very low certainty).
1 finding from 1 review
Reduction of of anxiety symptoms ‐ Clinician‐rated: LSAS total score · adults with SAnD
1 finding from 1 review